The presence of fluids in the subsurface can have a key influence on the processes and dynamics within active fault zones. Recent years have seen an increase in our understanding of the interaction ...

Subcutaneous immunotherapy for cancer can cause many of the same side effects as intravenous (IV) immunotherapy because it involves the same medications. Injection site reactions are a common but ...

The full results of a phase 3 clinical trial showed that patients with moderate-to-severe active systemic lupus erythematosus (SLE) who received standard treatment achieved greater reductions in ...

Five-Year Follow-Up of Standard-of-Care Axicabtagene Ciloleucel for Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium Subcutaneous amivantamab-lazertinib demonstrated noninferior ...

During the height of Super Smash Bros. Ultimate, the FGC flocked to Masahiro Sakurai’s X account to look for clues and hints on the next DLC fighter. They’d also get to see some insight into his life, ...

Keytruda Qlex is a new form of pembrolizumab, a cancer-fighting lab-made antibody that helps your immune system find and attack cancer cells. Unlike the original 30-minute intravenous (IV) drip, the ...

ROCHESTER, N.Y. — Seneca Park Zoo has made a treatment plan after Katya, a 20-year-old Amur tiger, was diagnosed with early-stage chronic kidney disease. Katya is the oldest tiger in any zoo part of ...

Six orphaned gray foxes were found and cared for at the Wildlife Care Center in Saratoga for the last four months before being released back into the wild at Alum Rock Park in San Jose on Aug. 20.

Learn how to turn leftover acrylic skins into one-of-a-kind pendants! This tutorial walks you through every step of making fluid art jewelry that’s both stunning and sustainable. Perfect for gifts or ...

Panelists discuss how subcutaneous (SubQ) drug formulations offer practical value by significantly reducing treatment times, easing staffing pressures, and enhancing efficiency in oncology practices, ...

Pucotenlimab in high microsatellite instability/mismatch repair–defificient (MSI-H/ dMMR) solid tumors: Results update from a multicenter, phase II, open-label study. This is an ASCO Meeting Abstract ...